Why the study?
The anti-platelets action of aspirin is not universal in all patients undergoing percutaneous coronary intervention (PCI).
This study aims to evaluate the prevalence and risk factors of aspirin non-responsiveness among patients undergoing PCI in Iraq.
Answers are grounded in this paper and cite their sources.
Aspirin nonresponsiveness occurs in stented patients; hypothesis-generating for regional prevalence and risk factors, prospective outcome trials needed.
Background: The anti-platelets action of aspirin is not universal in all patients undergoing percutaneous coronary intervention (PCI). We evaluated the prevalence and associated risk factors of aspirin nonresponsiveness in patients undergoing stenting in Duhok-Iraq.
No takes yet. Share an insight, caveat, or question.
Ameen Mosa Mohammad (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: